New Delhi. The Food Safety and Standards Authority of India (FSSAI) has expanded its scrutiny of Dabur India’s product labeling and health-related claims. According to an improvement notice dated August 19, the regulator has directed the company to conduct statutory audits of 27 product categories. It has also sought scientific evidence and human clinical trial data to substantiate several claims related to health benefits and immunity.
The review is not limited to the use of terms such as “100% pure,” “natural” or “organic.” The regulator is also examining claims that suggest health benefits or medicinal effects from certain products. The products under scrutiny include cold-pressed oils, apple cider vinegar, honey and other food items.
Proposal for Conducting Cyber Crisis Drill, Tabletop Exercise (TTEx) & CCMP Readiness Exercise
FSSAI has asked the company to provide scientific dossiers and data from peer-reviewed human clinical trials to substantiate health and immunity-related claims. The regulator has also questioned claims associated with cold-pressed sesame oil, including statements that it is “rich in antioxidants,” “good for heart health” and “helps reduce cholesterol.”
The company has been asked to submit scientific information and clinical evidence supporting these claims. It has also been directed to remove or withdraw such claims where required.
Similarly, the scientific basis of immunity-related claims associated with Glucose-D, coconut oil, honey and apple cider vinegar is being examined. Claims made for the company’s Siens brand are also part of the review. These include claims related to reducing wrinkles, promoting hair growth and increasing hair density. Clinical evidence has been sought to support these claims as well.
The regulator has also clarified requirements concerning disclaimers on product packaging. For brand names containing terms such as “Real” or “Homemade,” a clear disclaimer is required on the front of the package. Such information cannot be placed only in small print on the back of the packaging in a manner that makes it difficult for consumers to notice.
The action comes amid an ongoing dispute involving the use of “100%” claims on certain company products. Last month, FSSAI had directed that the sale of some food products carrying such claims be stopped immediately. The company subsequently sought judicial relief and received interim protection in the matter. The case is scheduled for further hearing in December.
Through the statutory audit of 27 product categories and its review of health-related claims, the regulator is examining whether the claims made on product packaging and in promotional material comply with applicable food safety and labeling standards.
The documents, scientific data and clinical evidence sought from the company will form an important part of the next stage of the regulatory review.
About the author — Suvedita Nath is a science student with a growing interest in cybercrime and digital safety. She writes on online activity, cyber threats, and technology-driven risks. Her work focuses on clarity, accuracy, and public awareness.
Follow for daily updates on cybercrime, corporate fraud, DFIR, hacking, investigations, and digital forensics
